Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Revuz

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Presse Medicale (Paris, France : 1983)|October 23, 2010
Hidradenitis suppurativaJean Revuz
Expert Opinion on Drug Safety|December 19, 2003
Thalidomide: an old drug with new clinical applicationsEmmanuel Laffitte, Jean Revuz
Dermatology (Basel, Switzerland)|July 8, 2010
Back and face involvement in hidradenitis suppurativaFlorence Poli, Pierre Wolkenstein, Jean Revuz
Archives of Dermatology|January 21, 2003
Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progressionNicolas Bachot, Jean Revuz, Jean-Claude Roujeau
Dermatology (Basel, Switzerland)|April 15, 2009
Lymph nodes in hidradenitis suppurativaXimena Wortsman, Jean Revuz, Gregor B E Jemec
The Journal of Investigative Dermatology|September 25, 2017
New Evidence Supporting Cyclosporine Efficacy in Epidermal NecrolysisJean-Claude Roujeau, Maja Mockenhaupt, Jean-Claude Guillaume, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Quality of life impairment in hidradenitis suppurativa: a study of 61 casesPierre Wolkenstein, Anderson Loundou, Karine Barrau, et al.
Medicine|May 11, 2010
Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysisMuriel Hello, Sébastien Barbarot, Sylvie Bastuji-Garin, et al.
Archives of Dermatology|February 18, 2003
Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patientsKiarash Khosrotehrani, Sylvie Bastuji-Garin, Jacques Zeller, et al.
Journal of the American Academy of Dermatology|September 10, 2003
Medical management of neurofibromatosis 1: a cross-sectional study of 383 patientsJean-Christophe Drappier, Kiarash Khosrotehrani, Jacques Zeller, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Presse Medicale (Paris, France : 1983)|October 23, 2010
Hidradenitis suppurativaJean Revuz
Expert Opinion on Drug Safety|December 19, 2003
Thalidomide: an old drug with new clinical applicationsEmmanuel Laffitte, Jean Revuz
Dermatology (Basel, Switzerland)|July 8, 2010
Back and face involvement in hidradenitis suppurativaFlorence Poli, Pierre Wolkenstein, Jean Revuz
Archives of Dermatology|January 21, 2003
Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progressionNicolas Bachot, Jean Revuz, Jean-Claude Roujeau
Dermatology (Basel, Switzerland)|April 15, 2009
Lymph nodes in hidradenitis suppurativaXimena Wortsman, Jean Revuz, Gregor B E Jemec
The Journal of Investigative Dermatology|September 25, 2017
New Evidence Supporting Cyclosporine Efficacy in Epidermal NecrolysisJean-Claude Roujeau, Maja Mockenhaupt, Jean-Claude Guillaume, et al.
Journal of the American Academy of Dermatology|November 14, 2006
Quality of life impairment in hidradenitis suppurativa: a study of 61 casesPierre Wolkenstein, Anderson Loundou, Karine Barrau, et al.
Medicine|May 11, 2010
Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysisMuriel Hello, Sébastien Barbarot, Sylvie Bastuji-Garin, et al.
Archives of Dermatology|February 18, 2003
Clinical risk factors for mortality in patients with neurofibromatosis 1: a cohort study of 378 patientsKiarash Khosrotehrani, Sylvie Bastuji-Garin, Jacques Zeller, et al.
Journal of the American Academy of Dermatology|September 10, 2003
Medical management of neurofibromatosis 1: a cross-sectional study of 383 patientsJean-Christophe Drappier, Kiarash Khosrotehrani, Jacques Zeller, et al.
Pageof 3